PharVision Advisers’s Hubbell HUBB Stock Holding History

PharVision Advisers’s Portfolio HUBB Stock Details HUBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-874	Closed	-$289K	–	347
2025 Q1	$289K	Buy	+874	New	+$338K	0.4%	98

Other funds holding HUBB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

PharVision Advisers's HUBB Position: Q2 2025 in Review

PharVision Advisers sold out of Hubbell (HUBB) in Q2 2025, closing a stake of 874 shares — an estimated $289K sold.

PharVision Advisers first reported a position in HUBB in Q1 2025 and held it in 1 quarter. The position peaked at $289K in Q1 2025. 866 funds tracked by Wall St. Rank hold HUBB as of Q2 2025.

PharVision Advisers reported no remaining Hubbell position as of Q2 2025 after selling out during the quarter.
PharVision Advisers sold 874 Hubbell shares in Q2 2025, an estimated $289K.
PharVision Advisers first reported a position in Hubbell in Q1 2025 and held it in 1 quarter.
PharVision Advisers's Hubbell position peaked at $289K in Q1 2025.
866 funds tracked by Wall St. Rank held Hubbell as of Q2 2025.

Based on PharVision Advisers's 13F filing for Q2 2025, filed 13 Aug 2025.